FDA
approval
· 2023-02-01
FDA Approved: CATAPRES-TTS-1 — Supplemental Application (Technomed Inc.)
Summary
FDA approved a supplemental application for CATAPRES-TTS-1 (clonidine transdermal system) by Technomed Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CATAPRES-TTS-1 (CLONIDINE TRANSDERMAL SYSTEM)